Related Experiment Videos
Osseous metastases from colorectal carcinoma
American Journal of Surgery
|April 1, 1986
Summary
This study on colorectal adenocarcinoma with bone metastases found a median survival of 7 months. Bone scanning is more sensitive than radiography for detecting bone metastases, and radiotherapy is effective for symptomatic cases.
Area of Science:
- Oncology
- Medical Imaging
- Radiotherapy
Background:
- Colorectal adenocarcinoma is a common cancer.
- Osseous metastases significantly impact patient prognosis.
- Understanding the diagnosis and treatment of bone metastases is crucial.
Purpose of the Study:
- To analyze survival outcomes in patients with colorectal adenocarcinoma and osseous metastases.
- To compare diagnostic sensitivity of bone scanning versus radiography.
- To evaluate treatment efficacy for symptomatic bone metastases.
Main Methods:
- Retrospective study of 66 patients with primary colorectal adenocarcinoma and osseous metastases (1970-1980).
- Analysis of disease-free interval and survival time.
- Review of diagnostic imaging (bone scan, radiography) and treatment modalities (radiotherapy).
Main Results:
- Median disease-free interval was 21 months.
- Median survival time from diagnosis of osseous metastases was 7 months.
- Bone scanning demonstrated higher sensitivity for detecting bone metastases compared to radiography.
- Radiotherapy was identified as the most effective treatment for symptomatic osseous metastases.
Conclusions:
- Osseous metastases in colorectal adenocarcinoma patients have a poor median survival.
- Bone scintigraphy is a more sensitive diagnostic tool than conventional radiography for bone metastases.
- Radiotherapy offers a viable treatment option for managing symptomatic osseous metastases.